[Patient with left ventricular aneurysm and thrombus after myocardial infarction - long-term observation]

Agnieszka Kwiecień-Sobstel1, Michał Zabojszcz, Michał Owsiak

  • 1Szpital Specjalistyczny im. J. Dietla, Kraków. agnieszkakwiecien@interia.pl

Kardiologia Polska
|April 28, 2011
PubMed

Insights

This case study tracks a patient with left ventricular aneurysm and thrombus following myocardial infarction over 14 years. It highlights managing thromboembolic and bleeding risks amidst evolving treatment guidelines.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Thrombosis Research

Background:

  • A 69-year-old male patient with a history of antero-septal myocardial infarction developed a left ventricular aneurysm and thrombus.
  • Long-term management of cardiovascular complications requires adapting to evolving clinical guidelines.

Observation:

  • The patient experienced recurrent thromboembolic events and significant bleeding complications during the 14-year follow-up period.
  • Treatment strategies were modified over time in response to changes in anticoagulation and antiplatelet therapy guidelines.

Findings:

  • Managing left ventricular thrombus in the setting of myocardial infarction presents a complex balance between preventing thromboembolism and minimizing bleeding risk.
  • Guideline evolution significantly impacts therapeutic decisions and patient outcomes in chronic cardiovascular conditions.

Implications:

  • This case underscores the critical need for individualized patient management in cardiology, considering both clinical presentation and guideline shifts.
  • Future research should focus on long-term outcomes and optimal therapeutic strategies for patients with left ventricular aneurysms and thrombi.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...